WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience Monoclonal Antibodies for Neuroscience Research
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, September 27, 2006, 26(39)

This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in J. Neurosci.
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

Next Article 

This Week in The Journal
This Week in The Journal

Formula Cellular/Molecular

Proton Inactivation of Choline Transporters

Hideki Iwamoto, Randy D. Blakely, and Louis J. De Felice

(see pages 9851–9859)

Choline transporters (CHTs) are concentrated at cholinergic nerve terminals at which these sodium-coupled transport molecules deliver the goods to the cytoplasm for subsequent acetylcholine (ACh) synthesis. Iwamoto et al. examined the biophysical properties of the human CHT expressed in Xenopus laevis oocytes. Several interesting properties emerged, including constitutive leakage current in the absence of substrate and variable stoichiometry of electrogenic transport. Their results may also solve a long-standing puzzle. Because CHTs can also transport ACh at high concentrations, and the transporters are highly expressed on presynaptic vesicles, transmitter could leak from ACh-containing synaptic vesicles. However, choline transport and current were inactivated at low pH. The authors hypothesize that the acidic pH in synaptic vesicles inactivates CHTs. However, once CHT-containing vesicles fuse with the plasma membrane, the neutral extracellular pH re-activates the transporter. It seems that CHTs come with a built-in ON–OFF switch.

Formula Development/Plasticity/Repair

MMP-2 and Wound Healing

Jung-Yu C. Hsu, Robert McKeon, Staci Goussev, Zena Werb, Jung-Uek Lee, Alpa Trivedi, and Linda J. Noble-Haeusslein

(see pages 9841–9850)

Proteolysis is not always a bad thing, according to the results of Hsu et al. In the immediate aftermath of spinal cord injury, inhibition of metalloproteinases (MMPs) can improve recovery, but only if the treatment is limited to the first few days. This pattern suggests that some MMPs have a positive effect during the later stages of wound healing and repair. The authors put the hypothesis to the test, focusing on MMP-2. Mice subjected to moderate spinal cord contusion injury expressed MMP-2 during wound healing, primarily in reactive astrocytes. This expression appeared to be beneficial, because MMP-2 null mice were impaired in locomotor function. MMP-2 null mice also developed a more extensive astrocytic scar in the injured spinal cord. Because scar formation is thought to inhibit the regeneration of injured axons, MMP-2 may act to provide a cellular environment more conducive to wound healing.

Formula Behavioral/Systems/Cognitive

Modulation of VPM Thalamic Units by the Locus Ceruleus

David M. Devilbiss, Michelle E. Page, and Barry D. Waterhouse

(see pages 9860–9872)

The noradrenergic neurons of the locus ceruleus (LC) influence sleep and wakefulness, as well as attention and feeding, through their diffuse projections. Devilbiss et al. sought to link the established cellular actions of norepinephrine to LC function. In a technical tour de force, the authors measured the effects of LC output on the sensory response properties of single neurons in the ventral posteriomedial (VPM) thalamus of awake, quietly resting rats. Microstimulation of the LC output enhanced norepinephrine influx in VPM and modulated the responses of individual units (neurons) to whiskerpad stimulation. Although units could show cell-specific behaviors, as a group, the responsiveness of VPM neurons was facilitated at low rates of LC stimulation but showed an inverted "U" response profile as LC stimulation increased. LC stimulation also altered correlated firing between groups of VPM neurons, effectively modulating their functional connectivity.


Figure 1
View larger version (40K):
[in this window]
[in a new window]
 
SH-SY5Y cells expressing the synuclein mutant A53T showed amyloidogenic aggregates (green) after differentiation for 5 d with retinoic acid. The cells were stained with an antibody against {alpha}-synuclein (red; left panel and merged) and thioflavin S (green; middle panel and merged). See Mazzulli et al. for details.

 
Formula Neurobiology of Disease

Cytosolic Dopamine and Synuclein Aggregation

Joseph R. Mazzulli, Amanda J. Mishizen, Benoit I. Giasson, David R. Lynch, Steven A. Thomas, Akira Nakashima, Toshiharu Nagatsu, Akira Ota, and Harry Ischiropoulos

(see pages 10068–10078)

This week, Mazzulli et al. explored the possible relationship between two events that can occur in Parkinson’s disease (PD): a decline in cellular dopamine concentrations and an increase in aggregates containing {alpha}-synuclein. Mutations in the gene encoding {alpha}-synuclein are responsible for some cases of familial PD. A number of factors can affect the initiation of synuclein fibril formation. In cell-free systems, dopamine interacts with {alpha}-synuclein and inhibits fibril formation by stabilizing oligomeric {alpha}-synuclein intermediates. The authors developed a cellular model system to examine this interaction. They engineered neuroblastoma cells to express either wild-type or mutant {alpha}-synuclein and varying amounts of tyrosine hydroxylase, the rate-limiting enzyme in dopamine synthesis. Retinoic acid-induced differentiation of cells expressing the A53T synuclein mutant increased synuclein aggregates. Increasing intracellular dopamine inhibited the transformation of mutant {alpha}-synuclein from soluble oligomers to Triton-insoluble aggregates.


Related articles in J. Neurosci.:

Cytosolic Catechols Inhibit {alpha}-Synuclein Aggregation and Facilitate the Formation of Intracellular Soluble Oligomeric Intermediates
Joseph R. Mazzulli, Amanda J. Mishizen, Benoit I. Giasson, David R. Lynch, Steven A. Thomas, Akira Nakashima, Toshiharu Nagatsu, Akira Ota, and Harry Ischiropoulos
J. Neurosci. 2006 26: 10068-10078. [Abstract] [Full Text]  

Matrix Metalloproteinase-2 Facilitates Wound Healing Events That Promote Functional Recovery after Spinal Cord Injury
Jung-Yu C. Hsu, Robert McKeon, Staci Goussev, Zena Werb, Jung-Uek Lee, Alpa Trivedi, and Linda J. Noble-Haeusslein
J. Neurosci. 2006 26: 9841-9850. [Abstract] [Full Text]  

Na+, Cl, and pH Dependence of the Human Choline Transporter (hCHT) in Xenopus Oocytes: The Proton Inactivation Hypothesis of hCHT in Synaptic Vesicles
Hideki Iwamoto, Randy D. Blakely, and Louis J. De Felice
J. Neurosci. 2006 26: 9851-9859. [Abstract] [Full Text]  

Locus Ceruleus Regulates Sensory Encoding by Neurons and Networks in Waking Animals
David M. Devilbiss, Michelle E. Page, and Barry D. Waterhouse
J. Neurosci. 2006 26: 9860-9872. [Abstract] [Full Text]  




This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in J. Neurosci.
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-